In this trial, giving patients simvastatin and rifaximin alongside standard of care did not reduce the risk of acute-on-chronic liver failure. Incidence of transplant or death was not ...

Objective: In order to assess the long-term (12 months) efficacy and safety of fenofibrate administered with simvastatin in the treatment of primary mixed hyperlipidaemia, we conducted a study ...